Lavo Life Sciences Analysis: $500K Raised
What is Lavo Life Sciences?
Lavo Life Sciences utilizes AI to enhance crystal structure prediction for small molecule drugs, streamlining drug development and reducing risks from unforeseen crystal forms.
Product Features & Capabilities
- AI-powered crystal structure prediction, fast and efficient crystal form identification, risk mitigation for unexpected crystal forms, optimization of drug formulations for stability and manufacturability, discovery of novel polymorphs, acceleration of drug development timelines, enhanced decision-m
How much Lavo Life Sciences raised
1 - $500,000
April 5, 2023Lead Investor: Y Combinator, Eastlink Capital
Who are the founders of Lavo Life Sciences
Market Focus
Lavo Life Sciences primarily focuses on the pharmaceutical industry, specifically in the area of drug development and formulation optimization through AI-accelerated crystal structure prediction of small molecule drugs.
Investors
- Y Combinator
- Eastlink Capital
- National Science Foundation
- BBQ Capital
- Gershon Capital
Competitors Overview
Lavo Life Sciences operates in the niche of AI-accelerated crystal structure prediction for drug development. Its main competitors include:
- XtalPi: This company leverages AI, quantum physics, and robotics to enhance pharmaceutical research. XtalPi is known for its comprehensive AI-driven pla
Business Model
Utilizes AI simulations for drug development; revenue from pharma partnerships and licensing.
See something that needs updating? Suggest edits to this profile.